Literature DB >> 12485441

Keratoacanthomas frequently show chromosomal aberrations as assessed by comparative genomic hybridization.

Ole Petter F Clausen1, Marzieh Beigi, Lars Bolund, Steen Kølvraa, Petter Jensen Gjersvik, Gro Mørk, Paula M de Angelis.   

Abstract

Keratoacanthomas are commonly occurring benign skin lesions localized to sun-exposed areas. They typically develop rapidly and may show cellular atypia and infiltration like cutaneous squamous cell carcinomas, but they finally regress spontaneously. This benign lesion shows a high degree of genetic instability as assessed by comparative genomic hybridization, with 35.7% (25 of 70) of the analyzed lesions harboring chromosomal aberrations. The same frequency of genetic imbalance was found in lesions from immunosuppressed organ transplant recipients (36.4%, 20 of 55) and in patients with keratoacanthomas without immunosuppression (33.3%, five of 15), indicating a common pathway in both situations. Recurrent aberrations, given as a fraction of lesions with aberrations, were gains on 8q (20.0%), 1p and 9q (each 16.0%), and deletions on 3p (20.0%), 9p (20.0%), 19p (20.0%), and 19q (16.0%). Many of the most frequently appearing aberrations in keratoacanthomas were not detected in any of the 10 squamous cell carcinomas analyzed, whereas some aberrations were shared by both types of lesions. Aberrations were found in early and late stages of keratoacanthoma development, indicating a role for genetic instability in the progression as well as involution of keratoacanthomas. There were no significant correlations between cytologic atypia and genetic imbalance, or between degree of infiltration and genetic aberrations, although there was a trend for keratoacanthomas with severe atypia to have aberrations. Thus malignant phenotypic development does not appear to be driven by the detected genetic aberrations. More detailed studies of chromosomal areas with recurrent aberrations are needed for the localization of putative genes that determine the biologic behavior of keratoacanthomas, and that may distinguish them from squamous cell carcinomas.

Entities:  

Mesh:

Year:  2002        PMID: 12485441     DOI: 10.1046/j.1523-1747.2002.19613.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  5 in total

1.  Analysis of loss of heterozygosity in Korean patients with keratoacanthoma.

Authors:  Tae-Won Ha; Ki-Hwan Han; Dae-Gu Son; Sang-Pyo Kim; Dae-Kwang Kim
Journal:  J Korean Med Sci       Date:  2005-04       Impact factor: 2.153

2.  Are keratoacanthomas variants of squamous cell carcinomas? A comparison of chromosomal aberrations by comparative genomic hybridization.

Authors:  Ole Petter F Clausen; Hans Christian D Aass; Marzieh Beigi; Karin J Purdie; Charlotte M Proby; Victoria L Brown; Morten Mattingsdal; Francesca Micci; Steen Kølvraa; Lars Bolund; Paula M Deangelis
Journal:  J Invest Dermatol       Date:  2006-05-25       Impact factor: 8.551

3.  Keratoacanthoma accompanied by multiple lung squamous cell carcinomas developing in a renal transplant recipient.

Authors:  Sadanori Furudate; Taku Fujimura; Aya Kakizaki; Yumi Kambayashi; Akira Hashimoto; Setsuya Aiba
Journal:  Case Rep Dermatol       Date:  2014-07-09

4.  Keratoacanthoma and Keratoacanthoma-Like Squamous Cell Carcinoma: Similar Morphology but Different Pathogenesis.

Authors:  Isabela C Watanabe; Renata F Magalhães; Aparecida M de Moraes; Rafael F Stelini; Geórgia F Cintra; Konradin Metze; Maria L Cintra
Journal:  Medicine (Baltimore)       Date:  2015-06       Impact factor: 1.889

5.  Keratoacanthoma of the Lip: Activation of the mTOR Pathway, Tumor Suppressor Proteins, and Tumor Senescence.

Authors:  Caroline Siviero Dillenburg; Manoela Domingues Martins; Luise Meurer; Rogerio Moraes Castilho; Cristiane Helena Squarize
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.